NR1I2 and metabolic dysfunction-associated steatotic liver disease: Thanks to the great advances recently achieved in the biotechnology field, soon it will be possible to perform detailed studies at a molecular level, involving nuclear receptors such as RXRs, PPARs or PXR that, as in “canonical” NAFLD, may play a key role in the underlying pathological mechanisms.